Japan Lipid Intervention Trial(J-LIT), a Follow-up Study of Simvastatin-Treatment Performed in Japan
The original article gave relative risk for each cause of death. Here the relative risk multiplied by the mortality for each cause is shown to visualize the contribution of each cause to all-cause mortality. It should be noted that this subject population included FH at 12-fold greater incidence than in general population (0.2%).2/4